US 8858946
Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies
granted A61KA61K2039/505A61K39/29
Quick answer
US patent 8858946 (Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies) held by THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS
- Grant date
- Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K39/29, A61P, A61P31/18